On the homepage
Health care
Out There
Crimefighting
Mental health
2 Minnesota firms team up on stent tests
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
Two Minnesota startups are joining forces to debut what they claim is a faster and more effective way to test drug-coated stents at the nation's premier biotechnology conference this week.
Nanocopoeia of St. Paul and the Integra Group of Brooklyn Park will announce today a new company called NanoInterventions whose core technology is a mouse-based testing system for drug-coated stents.
The new model can speed development of the experimental devices by testing them on mice, which, according to NanoInterventions, offer a better vehicle to replicate diseased human blood vessels. The announcement will come at the BIO conference in San Diego. BIO (Biotechnology Industry Organization) is the largest trade association for biotech companies. For more on this story, go to the Patent Pending blog at www.startribune.com/blogs/pending.
THOMAS LEE
Recent Business stories
Comments are temporarily unavailable
Our reader comments feature is currently undergoing maintenance. Please check back to comment on this story and join the discussion. We apologize for any inconvenience.
Blog: Patent Pending
Lights out at U energy conference. Irony police notified.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.